The non-adherence becomes an issue to be considered
when we want quality of health care as well as cost
containment and greater effectiveness of resources. Studies
of secondary prevention of ACS showed a cost reduction
around 10.1% to 17.8% among adherent and non-adherent
patients, corresponding to 294 and 868 dolars per patient